Abstract
The effect of selective D1 receptor agonists on acetylcholine (ACh) release in the striatum was investigated using in vivo microdialysis. Administration of the reactive enantiomer, (+)-SKF 38393 (2, 10 mg/kg s.c.), doses which elevate grooming and sniffing behaviour, increased ACh release by 40 and 75%, respectively. Another D1 receptor agonist CY 204-283 (1 mg/kg s.c.) also produced a 75% increase in ACh output. The racemate (±)-SKF 38393 (20 mg/kg s.c.) increased ACh output by 60% and this was completely blocked by the D1 receptor antagonist SCH 23390 (0.3 mg/kg s.c.). In contrast, administration of the D2 receptor antagonist raclopride (1 mg/kg s.c.), 60 min after (±)-SKF 38393 (20 mg/kg s.c.), further increased ACh release. These results suggest that activation of D1 receptors increases ACh release in vivo and that D1 and D2 receptors have opposing roles in the regulation of striatal ACh release.
Original language | English |
---|---|
Pages (from-to) | 335-338 |
Number of pages | 4 |
Journal | European Journal of Pharmacology |
Volume | 186 |
Issue number | 2-3 |
DOIs | |
Publication status | Published - Sept 21 1990 |
Externally published | Yes |
Bibliographical note
Funding Information:G.D. was supported, in part, by a grant from the Netherlands Organization for the Advancement of Research (NWO), G.S.R. is supported by a post-doctoral fellowship from the Canadian M.R.C. CY 208-243 was a generous gift of Sandoz, Basel and raclopride was kindly provided by Astra, Canada.
ASJC Scopus Subject Areas
- Pharmacology
PubMed: MeSH publication types
- Journal Article
- Research Support, Non-U.S. Gov't